Medical marijuana can help treat Alzheimer, depression, and other psychiatric conditions, according to a new study.
Researchers at the University of Washington found that the cannabis extract cannabidiol (CBD), which has been used for decades to treat conditions like cancer, anxiety, and epilepsy, could reduce the risk of developing Alzheimer’s, a degenerative brain disorder that attacks the central nervous system.
“The results of this study provide a compelling rationale for expanding the use of CBD in psychiatry, a field in which we currently have limited evidence,” said senior author John O’Malley, an associate professor of psychiatry at the UW School of Medicine.
“For some psychiatric disorders, such as schizophrenia, the use and abuse of cannabis can have negative consequences, such that some patients may suffer significant cognitive impairment and cognitive decline.
This study shows that there may be therapeutic benefits to the use, as well as safety and tolerability of cannabis extract in some psychiatric conditions.”
Researchers at Washington State University studied the use in 20 people with severe depression, including 17 with Alzheimer’s.
All participants were given either a placebo or a low dose of cannabigerol (CBT) or cannabicyclohexanol (CCH), both of which are used to treat schizophrenia.
Researchers followed the participants for up to 12 months.
During the study, they found that both groups experienced similar symptoms of depression, with only a single person with Alzheimer.
Researchers also found no evidence of side effects in either group.
“We were able to show that these patients have a significantly lower risk of cognitive impairment than the control group,” O’Lumsay said.
“This is important because people who are more impaired are less likely to seek help and may even be unable to get adequate care.”CBD and CBT are known to be effective in treating many other disorders,” O’tamah said.”
While it is difficult to say whether these results translate into an increased risk of Alzheimer’s or other dementias, it is very likely that we will be able to use this study to further explore this possibility.”CBD can have other benefits, too.
O’Malesay said that patients with Alzheimer can use CBD as an adjunct to medication to lower blood pressure and heart rate.
Other studies have shown that CBD can also help people with fibromyalgia and other pain syndromes.
The study appears online in the journal Molecular Psychiatry.
O’Malley is a member of the UW’s Department of Psychiatry.
He said he is particularly excited about this study because CBD can be very difficult to obtain, especially in the U.S. In fact, there are currently no federal or state laws that require the federal government to permit medical cannabis.”
In the U., we have a very limited supply of CBD, so it is a very hard sell to consumers,” O’dan said.
Department of Health and Human Services, which funds research in the field, recently set up a special program to ease the need for medical marijuana.
The Office of National Drug Control Policy, which regulates cannabis in the country, recently said that federal law prohibits the use or possession of the plant, but it will allow states to regulate the drug if they determine it has medical value.”
For more news videos visit Yahoo View, available now on iOS and Android.”
It’s very exciting to be able provide evidence that cannabis can alleviate the cognitive impairments that are common with Alzheimer disease.”
For more news videos visit Yahoo View, available now on iOS and Android.